Evidence map›Paper›PMID 9547226›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1998

Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease.

D J Stone, I Rozovsky, T E Morgan, C P Anderson, C E Finch

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 240 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Evidence of APOE4-related brain vulnerabilities in verbal memory systems in midlife women.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Women's midlife: the front line of Alzheimer prevention.The Journal of clinical investigation · 2026
    Review
  5. Article
  6. Review
  7. Alzheimer's disease protective allele ofmedRxiv : the preprint server for health sciences · 2024
    Article
  8. Sex as a Determinant of Age-Related Changes in the Brain.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Precision hormone therapy: identification of positive responders.Climacteric : the journal of the International Menopause Society · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

D J StoneAndrus Gerontology Center and the Department of Biological Sciences, University of Southern California, Los Angeles, California 90089-0191, USA.
I Rozovsky
T E Morgan
C P Anderson
C E Finch
University of Southern California · US

Funding

ApoJ (Clusterin) in Alzheimer's Disease and AgingR01AG013499 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FINCH, CALEB E · 1996 to 2006
$2.6M
NIA NIH HHS AG05766-0151NIA NIH HHS AG-13499NIA NIH HHS R01 AG013499
6 · The paper itself

Abstract

Estrogen replacement therapy appears to delay the onset of Alzheimer's disease (AD), but the mechanisms for this action are incompletely known. We show how the enhancement of synaptic sprouting by estradiol (E2) in response to an entorhinal cortex (EC) lesion model of AD may operate via an apolipoprotein E (apoE)-dependent mechanism. In wild-type (WT) mice, ovariectomy decreased commissural/associational sprouting to the inner molecular layer of the dentate gyrus, with synaptophysin (SYN) as a marker. E2 replacement returned SYN in the inner layer to levels of EC-lesioned, ovary-bearing controls and increased the area of compensatory synaptogenesis in the outer molecular layer. In EC-lesioned apoE-knock-out (KO) mice, however, E2 did not enhance sprouting. We also examined apoJ (clusterin) mRNA, which is implicated in AD by its presence in senile plaques, its transport of Abeta across the blood-brain barrier, and its induction by neurodegenerative lesioning. ApoJ mRNA levels were increased by E2 replacement in EC-lesioned WT mice but not in apoE-KO mice. These data suggest a mechanism for the protective effects of estrogens on AD and provide a link between two important risk factors in the etiology of AD, the apoE epsilon4 genotype and an estrogen-deficient state. This is also the first evidence that SYN, a presynaptic protein involved in neurotransmitter release, is regulated by E2 in the adult brain, and that apoE is necessary for the induction of apoJ mRNA by E2 in brain injury.

Indexed as

Estrogen Replacement TherapyMolecular ChaperonesAlzheimer DiseaseAnimalsApolipoproteins EClusterinFemaleGlycoproteinsImmunohistochemistryMiceMice, Inbred C57BLNerve Tissue ProteinsRNA, MessengerSynapsesSynaptophysinApolipoproteins EClu protein, mouseClusterinGlycoproteinsMolecular ChaperonesNerve Tissue ProteinsRNA, MessengerSynaptophysin

Identifiers

PMID9547226
PMCPMC6792662
OpenAlexW2109137609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.